A Message from the New Editor-in-Chief

Abstract

Cancer Research is the flagship publication of one of the largest scientific societies in the field and its most frequently cited journal. This exceptional resource has a long history of communicating studies of broad interest and high impact in basic, translational, and clinical aspects of oncology. Building on the outstanding leadership of the previous Editor-in-Chief and his team, the new editorial team seeks to continue to expand the breadth, influence, and quality of the journal, which is well situated to extend its stature as the field's leading scientific society journal.A key strength of Cancer Research is the interest of its content to the field as a whole, which encompasses a broad and diverse readership. Looking to the future, the incoming editorial team will continue to focus on publishing studies with the highest impact and broadest significance. We will also offer other content and editorial improvements to assist readers in gaining a cross-disciplinary grasp of diverse areas of the field. We will deepen the general core excellence in pathobiology, particularly in the exciting and rapidly growing areas of tumor microenvironment and immunology, capturing the most seminal work. Overall, the editorial team will work to continue the tradition of Cancer Research as the cancer community's most vital publication, strengthening its focus on broad-reaching, high-impact studies that inform solutions to the personal, clinical, and societal problems posed by cancer.The new editorial team has been expanded and rebalanced to reflect priorities for the journal as well as areas of expertise where submissions are received and distributed. Changes have been made in the categories for submission and in the number of editors in each category to improve editorial efficiencies. In particular, the number and balance in expertise of the Senior Editors and Editorial Board members who handle manuscripts has been matched more closely to the category in which manuscripts are received. By reducing the workload in high submission categories, this change should help enhance review efficiency. The roles and responsibilities for the different editors of the journal are as follows:Cancer Research has matured to become a highly translational enterprise. It is exciting to behold the field as it enters what may be a golden age of applications of modern concepts to create dramatic clinical improvements in cancer diagnosis, prognosis, and treatment. For those who seek the elimination of the scourge of disease, Cancer Research will continue to serve as the leading venue for publishing high-impact findings of the broadest significance to the field, along with other content to enlighten and integrate the field's efforts to change the fate of those suffering from cancer.